Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers

Gene fusions and MET exon skipping drive oncogenesis in 8–9% and 3% of non-small cell lung cancers (NSCLC) respectively. Their detection are essential for the management of patients since they confer sensitivity to specific targeted therapies with significant clinical benefit over conventional chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilson, Pauline, Pouget, Celso, Belmonte, Richard, Fadil, Smahane, Demange, Jessica, Rouyer, Marie, Lacour, Julien, Betz, Margaux, Dardare, Julie, Witz, Andréa, Merlin, Jean-Louis, Harlé, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412571/
https://www.ncbi.nlm.nih.gov/pubmed/37558711
http://dx.doi.org/10.1038/s41598-023-39749-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412571/
https://www.ncbi.nlm.nih.gov/pubmed/37558711
http://dx.doi.org/10.1038/s41598-023-39749-4

Ejemplares similares